 Aim of the study is to investigate whether Sildenafil treatment results in a reduction of pulmonary artery pressure without decrease of cardiac output CO and in improvement of exercise capacity in patients with heart failure with preserved ejection fraction HFpEF with pulmonary hypertension PH. 